Studies have found that the expression of ITGA2 is an independent prognostic marker of PAAD and is related to the grading and aggressiveness of PAAD (Shang et al., 2019; Yan et al., 2020). This evidence concerns the gene ITGA2 and pancreatic adenocarcinoma.